Neurodevice startups target peripheral nervous system

M. Eisenstein

DOI:10.1038/nbt1013-865

Corpus ID: 205271871

Neurodevice startups target peripheral nervous system

@article{Eisenstein2013NeurodeviceST,
  title={Neurodevice startups target peripheral nervous system},
  author={M. Eisenstein},
  journal={Nature Biotechnology},
  year={2013},
  volume={31},
  pages={865-866}
}

M. Eisenstein

Published 2013

Medicine, Biology

Nature Biotechnology

865 of Houston, Texas, made an initial €2 ($2.6)-million investment in Cerbomed, and ElectroCore of Basking Ridge, New Jersey, landed $40 million to develop its handheld vagus nerve stimulation (VNS) device from investors that include the Merck Global Healthcare Innovation Fund. Most recently, SetPoint Medical, of Valencia, California, became the first company to be selected for backing by GlaxoSmithKline’s Action Potential fund. Famm says this is only the starting point—his division is… CONTINUE READING

View on Nature